Recent Quotes (30 days)

You have no recent quotes
chg | %

Sirona Biochem Corp  

(Public, CVE:SBM)   Watch this stock  
Find more results for SBM
0.155
-0.010 (-6.06%)
Apr 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.16 - 0.17
52 week 0.09 - 0.19
Open 0.17
Vol / Avg. 286,500.00/530,472.00
Mkt cap 21.55M
P/E     -
Div/yield     -
EPS -0.03
Shares 139.03M
Beta -0.16
Inst. own     -
Mar 24, 2015
Sirona Biochem Corp at Biotechnology Industry Organization (BIO) Asia International Conference
  

Key stats and ratios

Q1 (Jan '15) 2014
Net profit margin - -1697.16%
Operating margin - -1672.91%
EBITD margin - -1660.14%
Return on average assets -106.77% -101.97%
Return on average equity -260.70% -174.99%
CDP Score - -

Address

889 Pender St W
VANCOUVER, BC V6C 3B2
Canada
+1-604-6414466 (Phone)
+1-604-6085471 (Fax)

Website links

Description

Sirona Biochem Corp is a Canada-based cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules. Sirona�s licenses its compounds to companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona�s laboratory, TFChem, is located in France. The Company�s programs include proprietary platform technology, pipeline, diabetes, skin lightening and anti-aging biological ingredients. The Company focusses on three programs: Therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; Cosmeceuticals, which includes anti-aging and depigmenting agents such as skin lighteners; and Biological Ingredients, which includes inducers and adjuvants for biological development and preservation. The Company has interests in TFCHEM S.A.R.L. (TFC), a biopharmaceutical company located in France.

Officers and directors

Howard Verrico M.D. Chairman of the Board, Interim Chief Executive Officer, Founder, Secretary
Christopher D. Hopton Chief Financial Officer, Director
Geraldine Deliencourt-Godefroy Chief Scientific Officer, Director
Attila Hajdu Chief Business Development Officer
Martin Gleave Director
Age: 53
David S. Moore Director
Age: 41
Michael Rogers Director
Nigel Andrew Terrett Director
Alex Marazzi Independent Director